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Abstract Structural and functional genomics initia-
tives significantly improved cloning methods over the
past few years. Although recombinational cloning is
highly efficient, its costs urged us to search for an
alternative high throughput (HTP) cloning method.
We implemented a modified Enzyme Free Cloning
(EFC) procedure, a PCR-only method that eliminates
all variables other than PCR efficiency by circum-
venting enzymatic treatments. We compared the
cloning efficiency of EFC with that of Ligation Inde-
pendent Cloning (LIC). Both methods are well suited
for HTP cloning, but EFC yields three times more
transformants and a cloning efficiency of 91%, com-
parable with recombinational cloning methods and
significantly better than LIC (79%). EFC requires only
nanogram amounts of both vector and insert, does not
require highly competent cells and is, in contrast to
LIC, largely insensitive to variations in PCR product
concentration. Automated protein expression screen-
ing of expression strains directly transformed with EFC
reactions showed, that the traditional preceding step
via a cloning strain can be circumvented. EFC proves
an efficient and robust HTP cloning method, that is
compatible with existing Ligation Independent Cloning
vectors, and highly suitable for automation.
Keywords Ligation independent cloning  Enzyme
free cloning  High throughput  Functional genomics 
Recombinant protein expression  PCR-only cloning
Introduction
The overwhelming amount of genome sequences
available and the large proportion of proteins without
reliable functional annotation, have led to a genome
wide functional analysis, generally referred to as
functional genomics or proteomics [1, 2]. In spite of the
lower accuracy of such high throughput (HTP) meth-
ods, a wealth of information on gene function and
functional relationships between geneproducts has
accumulated [3–6]. Recently, methods for the produc-
tion of smaller amounts of recombinant protein for
whole proteome analysis have become available [7].
The demand for large amounts of soluble protein for
structural and functional genomics boosted techno-
logical developments in recombinant protein produc-
tion in Escherichia coli over the past few years [8–10].
Most steps from gene to soluble protein can at present
be performed using a liquid handling station, which
dramatically increased the throughput and reduced the
costs through miniaturization [11]. These small-scale
expression-screening experiments predict sufficiently
well the production in larger quantities generally
required for downstream applications [12]. In an
ongoing effort to automate small-scale expression
screening, we searched for a cheap and efficient cloning
method that is robust enough to directly transform
expression strains with cloning reactions, thereby cir-
cumventing the intermediate isolation of plasmid DNA
from an E.coli cloning strain.
Traditionally, molecular cloning employs restriction
enzymes (RE) to digest DNA, which is enzymatically
joined using T4 DNA ligase. Although RE mediated
cloning is rather time consuming and needs a lot of
manual interference, it can be used for HTP cloning
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[13]. Recombinational cloning methods have been
successfully implemented in the HTP cloning of PCR
fragments and are particularly advantageous if a spe-
cific gene has to be cloned in many different vectors
[14]. Disadvantageous can be the presence of a
recombination site as part of the open reading frame,
which can affect protein function. Recombination
sequences are not translated, when placed outside the
open reading frame, but this requires large PCR
primers with Shine–Dalgarno or Kozak sequences
between the recombination site and the genespecific
termini, and it reduces the flexibility. Also, the need to
construct an entry clone prior to preparation of an
expression construct and the costs associated with
these methods are drawbacks when applied to HTP
protein expression in an academic environment.
A good alternative to recombinational cloning is
Ligation Independent Cloning (LIC) [15, 16]. This
procedure uses the exonuclease activity of T4 DNA
polymerase to generate 5¢ extended complementary
cohesive ends in both the vector and the PCR product.
A disadvantage of this method is the strict requirement
for correct T4 treatment of both insert and vector.
Furthermore, it is not entirely cloning vector and
sequence independent, because it relies on terminal
cloning sequences of 12–15 nucleotides lacking one
nucleotide type to generate complementary ends.
The hetero-stagger PCR method circumvents enzy-
matic treatments of PCR products by generating two
PCR products that each contain a cohesive end for a
specific restriction site on either the 5¢ or the 3¢ end of
the PCR product [17, 18]. This method was successfully
applied in the HTP screening of soluble recombinant
proteins [19]. Using hetero-stagger PCR cloning with
longer cohesive tails, Tillett and Neilan reported an
Enzyme Free Cloning (EFC) method that does not
depend on restriction sites [20, 21]. The absence of
enzymatic manipulations after PCR amplification sug-
gested that EFC could be useful in automated HTP
applications. Two disadvantages explain why EFC is
not a commonly used method. It is not straightforward
to prepare high quality vector DNA by PCR around
the vector on the large scale needed for HTP appli-
cations, and the need for two sets of gene-specific
primers creates additional costs. We can overcome the
first disadvantage by combining LIC-treated vectors
with EFC-created PCR products. Parallel oligonu-
cleotide synthesis led to a significant cost reduction,
making this modified EFC method now a potentially
attractive HTP cloning method.
To evaluate the utility of EFC in HTP cloning in an
unbiased pairwise comparison with LIC, we applied
both methods to clone 24 different PCR products into
identical LIC compatible vectors. All PCR products
can be cloned reliably by both methods, but with
higher efficiency by EFC. We show that this cloning
method is fast, does not require gelpurification of PCR
products and requires only nanogram amounts of both
insert and vector DNA in combination with house-
made chemically competent cells. Furthermore, it can
be completely performed using a liquid handling
station or multichannel pipettes, demonstrating the
feasibility of EFC as a HTP cloning method.
Material and methods
Plasmids
The plasmid pLICHIS was obtained by cloning in the
NcoI and BamHI sites of pET15b two annealed oli-






Trx and GST fusions were constructed by inserting the
PCR fragments of the respective fusion tags amplified
from respectively pTrx-Fus (Invitrogen), pGEX2T
(GE-Healthcare), and pTH3 [22] in the NcoI-NdeI
sites of pLICHIS. Dual tag plasmids HIS-GST, HIS-
Trx and HIS-GB1 were made by insertion of a ds oli-
gonucleotide with NcoI overhang in the NcoI digested
fusions. The S-tag fusion was constructed by inserting





GCAGCAGCGGTTTCTTTCA in the NdeI and
SacII digested pLICHIS. All constructs were sequence
verified. Details on construction of these vectors are
available upon request.
EFC
For PCR amplification, two sets of primers were
designed, (Eurogentec, genomic primers, at 10 or
50 nmol without further purification) where the
gene-specific sequence is extended either with
GCCGCGCGGCAGCCTG-gene-specific (LICFW) or
TG-gene-specific (FW) as forward primers and CA-
AGAAGAACCCCTCA-gene-specific (LICRV) or
TCA-gene-specific (RV) as reverse primer respec-
tively. PCR products were amplified in two separate
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tubes, one with LICFW combined with RV, and one
with FW combined with LICRV, using cDNA pre-
pared as described before [12]. When plasmid DNA
was used as PCR template, it was digested with
the methylation dependent restriction enzyme DpnI
(MBI Fermentas) after PCR amplification. To remove
primer dimers and non-consumed primers, PCR prod-
ucts were purified using the AMPure PCR purification
method (Agencourt) according to instructions of
the company using either multichannel pipettes or
a Hamilton Star liquid handling station. About
1–100 ng of the two PCR products were mixed and
incubated for 5 min at 95C and slowly cooled to
25C in at least 5 min (PCR block or water bath).
This hybridized PCR product was mixed with 2 ng of
T4 treated pLICHIS (as described under Ligation
Independent Cloning) in a total volume of 5 ll,
incubated at room temperature for 5 min, and trans-
ferred to an ice bath. A total of 25 ll of DH5a
competent cells (CaCl2 method [23], 1105–3106 col-
onies/lg plasmid DNA) was added to the reaction
mixture, incubated on ice for 30 min, heat shocked for
60 s at 42C, and recovered for 30 min at 37C in 75 ll
LB. A total of 60 ll of the transformation mixture was
transferred to 12-well LB plates containing 50 lg/ml
ampicilin and distributed equally by twisting the plates,
followed by 15 min drying at 37C without lid. During
transformations in the expression strain BL21(DE3)
Rosetta2-LysS (Novagen), the transformation mixture
was plated on LB amp plates containing 35 lg/ml
chloramphenicol. Protein expression and detection was
performed as described before [12].
Ligation independent cloning
pLICHIS was digested with SacII (NEB) or Cfr42I
(MBI Fermentas) for 4–16 h and dephosphorylated
using CIAP (MBI Fermentas), and gelpurified using
the QiaexII gel extraction kit (Qiagen). A total of
500 ng of vector was treated with 0.3 units of T4 DNA
polymerase (NEB) in the presence of 2.5 mM dTTP in
T4 polymerase buffer (33 mM TrisAc pH 7.9, 10 mM
MgAc, 66 mM KAc, 0.1 mg/ml BSA, 0.5 mM DTT),
incubated for 25 min at 20C and subsequently heat
inactivated for 20 min at 70C. PCR products were
PCR amplified using the LICFW and LICRV primer
and purified as described above. A total of 100 ng of
PCR product was treated with 0.3 unit of T4 DNA
polymerase (NEB) as described for the vector but with
2.5 mM dATP instead of dTTP, in T4 polymerase
buffer. About 1–100 ng of T4 treated insert and 1–3 ng
of T4 treated vector were mixed together and trans-
formed to DH5a as described above.
Results
Experimental setup
An ideal cloning method should require small amounts
of insert and vector DNA, and be cheap, effective,
easily automatable and insensitive to variations in
DNA concentrations [24]. Ligation independent clon-
ing [15] meets most of these criteria, but we observed
substantial variation in cloning efficiency. Parameters
influencing efficiency are the amount of PCR product,
purity of the PCR product, exact temperature of T4
DNA polymerase treatment and T4 DNA polymerase
activity differences, caused by enzyme batch variations
and activity loss over time (unpublished results). As a
result, PCR products can be under- or overtreated by
the exonuclease activity of T4 DNA polymerase, which
can significantly influence the cloning efficiency.
The Enzyme Free Cloning method we implemented
here, deviates from the EFC published before [21]. We
use a LIC reaction [15] to generate the vector over-
hangs instead of a vector-long PCR reaction, which
enabled us to make much larger preparations of EFC
compatible vector as needed for constant HTP cloning
quality. We use the hetero-stagger PCR method for
gene amplification [17] to create cohesive termini
complementary to the T4 treated vector and circum-
vent the T4 treatment of PCR product needed for LIC.
This combination of methods effectively should elimi-
nate all variables during cloning except for the PCR
efficiency. The EFC method requires two sets of gene-
specific PCR primers, since one forward and one reverse
primer are extended with a sequence complementary to
the termini of the T4 treated vector. Two separate PCR
reactions are performed, one with the extended forward
primer (1) and a normal reverse primer (3), and one with
a normal forward (2) and an extended reverse primer
(4). The two PCR products are purified, mixed, dena-
tured and renatured, creating cohesive termini in which
25% of the possible combinations are compatible with
the T4 treated vector (Fig. 1d).
In this setup, we can use an identical vector for both
EFC and LIC, which allows us to do a pairwise com-
parison of the two cloning methods that is unbiased by
the chosen vector. We constructed a LIC compatible
vector pLICHIS (Fig. 1b) and derived various fusion
proteins by inserting GST, Trx or GB1 in between the
HIS-tag and the LIC site. All plasmids have a pET15b
plasmid backbone, 14 basepairs of the thrombin
cleavage site that are a LIC compatible sequence
because they lack thymidines, followed by a SacII site
and a 13 bp reverse LIC site lacking an adenosine. A
digestion with SacII and exonuclease treatment using
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T4 DNA polymerase in the presence of dTTP gener-
ates a non-self complementary overhang, identical for
all vectors, that permits efficient cloning of T4 treated
PCR products in vectors with different fusion tags
(Fig. 1).
Enzyme free cloning is a robust cloning method
Various amounts of PCR products were either treated
with T4 DNA polymerase for the LIC method, or
mixed for EFC and hybridized with increasing amounts
of the same T4 treated vector resulting in a molar
insert/vector ratio ranging from 2 to 2000. A vector
concentration dependent increase in the amount of
colonies was observed for both methods (Fig. 2a, b).
While for EFC increasing amounts of both vector and
insert stimulated colony formation, remarkably, we
observed that LIC displayed a significant drop in
cloning efficiency at higher insert concentrations. The
insert concentration dependence for LIC is probably
caused by an incorrect ratio of T4 polymerase and PCR
product during exonuclease treatment. To test this
hypothesis, a T4 treated PCR product was diluted, and
various amounts were hybridized with different
amounts of vector. Under these circumstances, LIC
cloning effciency increased with insert concentration
similar to EFC (Fig. 2c), showing that the efficiency of
T4 treatment is significantly influenced by the PCR
product concentration. Under all conditions EFC
resulted in more colonies than LIC, with an average
increase of 2.6 ± 1.3 fold more colonies per ng of PCR
product. The overall number of correct cloning events
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Fig. 1 Plasmid and cloning procedure. (a) Nucleotide sequence
of cloning site of pLICHIS and restriction sites used for
construction of the various fusion tags. The plasmid sequence
outside the NcoI and BamHI fragment is identical to pET15b.
Translated protein is indicated below, with the thrombin
cleavage site in bold. The LIC extensions are underlined and
the dTTP nucleotide or its complement incorporated by T4
DNA polymerase is indicated in bold. The SacII site used for
linearization prior to T4 treatment of the vector is indicated. (b)
Schematic representation of the plasmids constructed for small
scale expression screening. X-tag refers to either a GST-tag
(pLICGST), Thioredoxin (pLICTrx) or Gb1 (pLICGb1) tag, or a
combination of the HIS tag with a GST tag (pLICHISGST), a
Thioredoxin tag (pLICHISTrx), a Gb1 tag (pLICHISGb1), or an
S-tag (pLICHISS). Indicated are the T7 promoter (T7), T7
terminator (T7t), lac operon (Lac), ribosomal binding site (R),
LIC forward site (LF) and LIC reverse site (LR). Gene refers to
the inserted gene sequence, while the dashed lines indicate the
absence of sequences present in the other vectors. (c) Overhang
of the PCR amplified target protein with the dATP nucleotide
and its complement that will be incorporated by T4 DNA
polymerase indicated in bold. (d) For EFC, a LIC compatible
overhang is created using two different primer sets as described
in detail in the Materials and Methods section. The LIC
sequence extended primers 1 and 4 and the non-extended
primers 2 and 3 are used for PCR amplification as schematically
depicted. After mixing, denaturing and reannealing of the two
PCR products, 25% of the PCR products contain a LIC-
compatible overhang
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The EFC method relies on the formation of the
hybrid between two PCR products with different
extensions. Although PCR is quite robust, it can be
anticipated that in HTP applications the two PCR
reactions of each target will not be equally efficient. To
test the effect of such variations on the cloning effi-
ciency, molar ratios of the two PCR products to be
hybridized were varied, ranging from 30:1 to 0.03:1. As
shown in Fig. 2d, in the absence of PCR product no
colonies were obtained, while when only one PCR
product was present, we observed either no or one
colony that appeared to be an empty vector (data not
shown). Colonies were obtained at all molar ratios,
which appeared to contain the correct insert in most of
the cases (89%, N=56). We only observed a significant
decrease in the number of colonies at the most skewed
ratio’s, while under all other conditions a comparable
number of colonies was obtained.
Since DNA concentration variations of both insert
and vector and the relative ratio of the complementary
PCR products all have only a minor effect on the
cloning efficiency, we conclude that EFC should be
robust enough for HTP cloning.
EFC is a highly efficient cloning method
To test the suitability of EFC for HTP cloning, 24
different targets were selected (Table 1) and PCR
amplified according to both the EFC protocol and the
LIC protocol. All targets except clone 21 were suc-
cessfully amplified from both reverse transcribed
cDNA (Fig. 3) and plasmid DNA (data not shown),
and all amplified targets could be successfully cloned
using both methods. Two distinct bands were obtained
for clone six, the larger of the anticipated size, the
smaller most probably a PCR artifact; the majority of
the plasmids contained the smaller PCR artifact. The
absence of such artifacts from the PCR using LIC
primers is not a general observation and probably due
to experimental variation. Initially PCR amplification
of clone 21 failed (Fig. 3a) and, as expected, we were
unable to clone this PCR product both using EFC and
LIC. After reamplification of both clone 21 and 6 using
a new batch of cDNA and addition of 5% glycerol and
5% DMSO, products of the expected size were
obtained and successfully cloned using both methods


















































































Fig. 2 Cloning efficiency for LIC and EFC. (a–c) Number of
colonies obtained after transformation of EFC or LIC reactions
in DH5a with the indicated amount of insert and vector, using
the same insert prepared by (a) EFC reaction or by LIC reaction
with T4 treatment using the same amount of T4 DNA
polymerase either (b) after dilution or (c) before dilution of
the PCR products. Representative experiments are shown. (d, e)
Influence of the ratio between the two different PCR products on
the EFC efficiency. (d) The number of colonies obtained after
transformation of EFC reactions in DH5a, where the two PCR
products were mixed in different ratios ranging from 30:1 to
1:0.03. The controls included were without (-) or with only one of
the two PCR products present in the EFC reaction (> and <).
The average ± standard deviation of three independent exper-
iments is shown. (e) The fraction of correct cloning reactions
(efficiency) as determined by the fragment sizes obtained after
PCR amplification of the insert of the plasmid, using purified
DNA of the transformants under the experimental conditions
described for d
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Cloning of a comparable amount of either the LIC
treated PCR product or the two mixed PCR products,
using the same T4 treated vector in the same competent
cells, resulted in 2.4 ± 1.4 fold more transformants
using the EFC approach. Four independent experi-
ments were performed with two different batches of
PCR products and two different vectors using two dif-
ferent competent cell preparations (Fig. 3b, and data
not shown), showing a reproducibly better result for
EFC than for LIC in agreement with the results pre-
sented in Fig. 2. For each target, 10 colonies from three
independent experiments were analyzed by PCR using
plasmid specific primers, showing a success rate of 91
and 79% for EFC and LIC respectively (Fig. 3c, and
data not shown). Using EFC, only a small fraction
(14%) of the incorrect constructs (N = 21) had no in-
sert. Few contained primer dimers (24%), while the
remainder of the failures were incorrectly sized PCR
artifacts (33%), or contained deletions not attributed to
incorrect PCR amplification (29%). For LIC a compa-
rable error distribution was found (data not shown).
Since we used standard Thermus aquaticus DNA
polymerase, lacking 3¢–5¢ exonuclease (proofreading)
activity, PCR products with 3¢ extensions are formed
(‘‘extendase activity’’), which might be incorporated
into the plasmid. DNA sequencing of the vectors never
revealed frameshifts due to this extendase activity,
neither with EFC, nor with LIC (data not shown).
Over 60 plasmids were sequenced; all but one construct
were correctly inserted. The single failure was most
probably due to incorrect priming of a primer with the
plasmid template (data not shown).
As observed before (Fig. 2b), the EFC method was
not sensitive to differences in the PCR amplification
efficiency of the two products (e.g. 10, 13, 14, 16). The
length of the fragments only marginally influenced
Fig. 3 Pair wise comparison between EFC and LIC for HTP
cloning. The left panel shows the results obtained for EFC, while
the right panel shows the data for LIC. (a) The RT-PCR
amplification of the 24 different targets after PCR product
purification. Note that for EFC target 6 a PCR product of
incorrect size was obtained for both primer sets. For target 21 the
first RT-PCR reaction for both EFC and LIC failed. Amplifica-
tion of these failed reactions using a new batch of cDNA and
addition of 5% glycerol and 5% DMSO resulted in the correct
fragments. For further analysis the data obtained for the
reamplified product for clone 21 for both EFC and LIC were
used. (b) The number of colonies obtained after transformation
of 10–100 ng PCR product (depending on the PCR efficiency)
hybridized with 3 ng vector DNA in DH5a. (c) The fraction of
correct cloning reactions for the different targets as determined
by the fragment sizes obtained after PCR amplification of the
insert of the plasmid, using colony PCR or purified DNA. Data
are the average ± standard deviation of three independent
experiments using in total 10 colonies for every target using
both methods
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cloning efficiency; we have successfully cloned frag-
ments up to 2000 basepairs. Finally, also if PCR
amplification was less efficient, cloning could be per-
formed, albeit with a lower success rate (Fig. 2a, data
not shown). Overall we conclude that, provided primer
dimers are removed, all correctly amplified PCR
products can be successfully cloned by both LIC and
EFC, EFC being significantly more efficient than LIC.
EFC is suitable for small-scale expression screening
The high cloning efficiency suggests that EFC can be
used in HTP small-scale expression screening as an
alternative to LIC. We transformed the expression
strain BL21(DE3) Rosetta2-LysS either with EFC
cloned plasmids isolated from DH5a, or directly with
EFC reactions and evaluated protein expression. All
direct transformations were successful as judged by
the number of colonies obtained after transformation
(ranging from 2 to 30 colonies with a transformation
efficiency of 2 · 105 colonies/lg of plasmid DNA).
Transformation using sequencing verified plasmids,
and direct transformation of EFC reactions resulted
in largely comparable protein expression (Fig. 4a).
Differences in the protein expression levels were
probably due to experimental variation and are
frequently observed in small-scale expression screen-
ing (unpublished observations). In contrast to verified
plasmid transformation, the direct transformation of
the EFC reaction of clone 21 did not yield detectable
protein expression, most likely caused by the poor
quality of the PCR amplification (Fig. 2a). Further-
more, for clone 6 the smaller PCR product was cloned
and expressed.
To test the reproducibility of the direct transfor-
mation of EFC reactions, we analyzed the protein
expression of eight individual colonies for each clone
that expressed significant amounts of protein in Fig. 4a.
As a control, expression of 4 colonies from the trans-
formation of a verified plasmid was performed.
Figure 4b shows that, like for plasmid transformation,
essentially all EFC reactions showed expression of the
expected protein. The overall success rate for direct
transformation of EFC reactions, 94% (n=80), is
comparable with the results obtained above (Fig. 2, 3).
Most importantly, both qualitatively (Fig. 4a) and
quantitatively (Fig. 4b), protein expression by direct
transformation of EFC reactions was only slightly less
efficient than expression by transformation of verified
plasmids. We conclude that EFC reactions can be used
for small-scale expression screening of PCR products
without the time consuming intermediary cloning step
in a general purpose E.coli cloning strain.
EFC proves reliable in High Throughput Cloning
To verify the utility of EFC for HTP cloning, we tested
its efficiency in the cloning and expression of 222 tar-
gets ranging from 4 kD to ~200 KD unrelated to the
previous test group (Table 2). We amplified 210/222
targets successfully from cDNA, while after EFC and
transformation to home-made competent DH5a cells,
colonies were obtained for over 98% of all reactions.
One colony was selected for each reaction, and PCR
analysis revealed a success rate of 65%. For failed
reactions, three more colonies were analyzed, of which
52% appeared correct. In total, we screened 450 col-
onies to obtain 180 constructs, being 86% of all suc-
cessfully amplified PCR products (data not shown).
Failures were generally caused by either poor PCR
amplification or the presence of PCR products of
unexpected size. Since we performed cDNA amplifi-
cations, such incorrectly sized PCR products could also
result from alternatively spliced mRNA’s. Small scale
protein expression screening of EFC cloned plasmids
revealed that over 80% of all succesfully cloned con-
structs expressed a protein of the expected size as
judged by SDS-PAGE (data not shown). We conclude
that EFC can be used as a HTP cloning method.
Table 1 Targets used for comparison of the EFC and LIC
cloning methods. A SwissProt accession number is given if
available, otherwise a GenBank accession number is shown (#).
Most common gene name, first and last amino acid and size (base
pairs) of the PCR amplified fragment are shown
SwissProt Gene First residue Last residue PCR-size
Q64252 eIF3S6 327 411 288
Q9Y5B5 usp15 1 120 393
Q92541 KIAA0252 345 476 429
Q9C0C8 KIAA1735 408 490 282
Q9Y4E8 HRPT2 358 526 540
Q8TEY7 Usp33 713 942 723
P78344 I4G2 540 669 423
P78332 NY-LU12 1027 1123 324
Q86VG0 VHLAK 1 151 486
Q96GC6 hfb101 148 347 633
Q86UW6 B3BP 1657 1770 375
Q8IWZ8 SF4 187 253 234
Q9NVV9 THA1 1 90 303
O75312 ZPR1 212 423 669
Q92926 BAF60C 252 321 243
Q15424 SAF-B 26 69 165
O75398 DEAF2 200 274 258
O14640 Dishevelled1 387 475 300
O60381 HMGBP1 208 338 426
Q9Y6K1 DNMT3A 289 362 255
4104419# HNF6 278 384 354
665918# RO52 285 338 195
Q96L91 p400 765 835 246
Q9P2D1 CHD7 1802 1860 210
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Discussion
We have compared Ligation Independent Cloning with
a modified Enzyme Free Cloning method and show
that EFC yields a higher total number of colonies
(Fig. 2b), that EFC yields a higher fraction of correct
colonies (Fig. 2c) and that EFC is more tolerant to low
amounts of vector and insert (Fig. 2a). We show that
every successfully amplified PCR product can be
cloned using EFC, while the cloning efficiency is only
marginally influenced by the ratios of the two PCR
products (Fig. 2b). We established the usefulness of
this method in HTP applications by cloning 222 targets,
and show that after successful PCR amplification,
provided that sufficient amount of vector (1–3 ng) is
used, the success rate is only marginally influenced by
the PCR amplification efficiency (Fig. 2, 3, and data
not shown) or fragment size within the tested range
from 150 bp to approximately 2 kb (Fig. 3 and data not
shown). Evaluation of all EFC experiments revealed
an average efficiency of 2.9 colonies per ng PCR
product using 1–3 ng of T4 treated vector and com-
petent cells with an efficiency of 106/lg DNA. There-
fore, we advise to use at most 2 ng of vector and
preferably three or more ng of PCR product in high
throughput applications. Additionally, we observed
that EFC is also an efficient method for site directed
mutagenesis and multiple fragment cloning (not
shown), in agreement with published data [25].
Cloning efficiencies reported here for EFC are
comparable to the Invitrogen Gateway and Clontech
In-Fusion system determined in a pairwise comparison
of these two systems [24] for the size of fragments
cloned here (< 1 kb). Although LIC is used by many
structural genomics groups [26, 27], its use is not as
widespread as recombinational cloning methods [7, 8,
14, 28, 29]. Dieckmann et al. have shown that LIC can
be used for prokaryotic expression vector preparation,
but they did not report on efficiencies of the cloning
reactions [26]. Given the large percentage of expressed
proteins reported by this group, using LIC, efficiency
should approach 90%. The commercially available LIC
vectors of Novagen claim to have recombination effi-
ciencies greater than 95%, although we are not aware
of data supporting these efficiencies. In our hands we
obtain a slightly lower cloning efficiency for LIC
reactions using all in house made reagents, which is
probably due to the presence of PCR artifacts in the
Fig. 4 EFC for HTP small-
scale expression screening. (a)
Total protein expression in
BL21 Rosetta-LysS that were
transformed by either EFC
cloned plasmids isolated from
DH5a (lower panel) or
directly using EFC reactions
(upper panel). For direct
transformation, 10–100 ng of
PCR product (Fig. 3a) was
hybridized with 3 ng T4
treated pLICHIS. A total of
15 ll of IPTG induced
cultures grown under
identical conditions were
analyzed by SDS-PAGE. (b)
After direct transformation of
EFC cloning reactions
(direct) or verified plasmids
(plasmid), respectively, 8 and
4 colonies were tested in
small-scale expression
screening. Total protein
expression for the various
targets is shown. Arrowheads
indicate the overexpressed
proteins
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cloning reactions such as primer dimers and inappro-
priate PCR products. These can easily be removed by
gel purification of PCR products, although this is not
ideal in a HTP cloning protocol. Results from several
groups [26, 27] including our unpublished experience
and experiments presented here (Fig. 2, 3), show that
LIC is a reliable cloning method albeit less efficient
than EFC.
Crucial for efficient EFC was the removal of primer
dimers. Different PCR cleanup methods that fail to
completely remove PCR artifacts produce undesirable
numbers of false positives (data not shown). With the
currently used PCR cleanup method only 24% of the
failed cloning attempts, being 2% of all analyzed
(n > 300), gave primer dimers. Empty vectors were
infrequently found (14% of the failed reactions, 1% of
all reactions). The cloning of PCR artifacts or unde-
fined rearrangements between vector and insert caused
the remainder of the failures (62%). Importantly, the
type of errors and the relative frequency of occurrence
for EFC and LIC are comparable. Furthermore,
although differences in ratio’s of the two PCR products
are well tolerated (Fig. 2B), correct PCR amplification
of both fragments is preferred for high efficiency
cloning as illustrated by the high frequency of failures
obtained when no or a smeary PCR product (e.g. clone
21) or an additional PCR fragment was present
(e.g. clone 6, 18).
The most important disadvantage of the EFC
method are its additional costs. The necessity for two
sets of primers, requiring on average 40 additional
nucleotides per cloning reaction in comparison with
LIC, and the double PCR reaction and purification
makes this method more expensive than LIC. These
additional costs associated with the EFC method could
be decreased using two universal adaptor primers for
all PCR products that encode the vector compatible
overhang and recognize a standardized 5¢ end of gene
specific primers. Advantageous is the higher success
rate, which reduces the number of transformants
that need to be analyzed. We further show that the
transformation in a cloning strain and subsequent
plasmid isolation can be omitted with EFC for small-
scale expression screening (Fig. 4). The reproducibility
of the direct transformation EFC method was
underscored by the small percentage of colonies
(~10%) that failed to express the protein (Fig. 4b).
This increases the throughput, and reduces the costs
associated with the normally used protocol.
Altogether, we feel that the limited additional costs of
40 nucleotides for an additional primer set are well
balanced by the absence of enzymatic treatments after
PCR and the increased efficiency and throughput.
The EFC method as proposed by Tillett and Neilan
(20) uses a vector that is PCR amplified also using
EFC, making cloning completely independent of vec-
tor sequences. We were unable to prepare vectors
consistently in the quantities needed for HTP appli-
cations (unpublished results). By combining a T4
treated vector and a hetero-staggered PCR product,
we extend the versatility of EFC applications. More-
over, existing LIC vectors are perfectly compatible
with EFC. Extrapolating the EFC cloning efficiency
and using commercially available chemical competent
cells (108/ug), we should expect approximately 105
colonies when 10 ng of vector and 50 ng PCR product
are used. Such efficiencies should make it possible to
efficiently perform applications like e.g. library con-
struction for putatively interacting proteins, domain
swapping, antibiotics resistance gene swapping or
promoter swapping. We currently evaluate some of
these applications.
We expect that through the implementation of this
cloning method, we will be able to completely auto-
mate small-scale expression screening. The reported
EFC efficiencies, the ability to directly clone PCR
products in an expression strain without a subcloning
step, and the ability to automate these experiments,
will greatly facilitate small-scale expression screening,
and holds the promise to increase the throughput of
protein production for functional and structural
genomics.
Table 2 Summary of the EFC cloning of 222 targets. All gene
fragments were amplified from a home-made cDNA library,
cloned using EFC in DH5a. Plasmids were isolated and protein
was expressed in Rosetta2 -pLysS. At each protein production
step, both the successrate per step and overall successrates are
indicated. Poor quality PCR: PCR reactions containing very faint
bands, additional bands of unexpected height, smears or primer/
dimer artifacts. Good quality PCR: PCR reactions with a clear
band of correct size
Success per step (%) Overall fraction (%)
Targets selected (N = 222) 100 100
detectable PCR amplification 95 95
(of which: poor quality) (8)
(of which: good quality) (86)
Cloned 86 81
expressed 80 65
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